End-Stage Kidney Disease

Monogram Health, a company focused on providing management services for patients with kidney disease, has expanded access to its in-home kidney care management program, allowing for more Cigna Medicare Advantage members to join it.

Having a first-degree relative with a history of end-stage kidney disease did not appear to increase the risk for long-term kidney function decline or hypertension in African American kidney donors, according to study results.

A meta-analysis of clinical trials suggested that diet therapy focused on lowering serum phosphate levels may be safe and effective for patients on hemodialysis, but researchers emphasized that further investigation is required.

Cara Therapeutics has submitted a new drug application to the FDA for its injectable form of difelikefalin, a medication designed to treat moderate-to-severe pruritus in patients on hemodialysis.

A majority of patients with kidney failure were deemed ready for increased utilization of mobile health based on reported availability of necessary devices, as well as proficiency and interest in the technology.

A study of patients on hemodialysis found potassium levels that deviate outside of the target range may be a more accurate predictor of hyperkalemic events than a single measurement or time-averaged values.

New research highlights a broad range of heart, lung and kidney complications in patients who were diagnosed with COVID-19. It was the top story in cardiology last week.

Through an analysis of electronic health record data, researchers from Geisinger determined patients with kidney disease are more likely to be hospitalized with COVID-19 vs. patients with other preexisting conditions.

Accountable care organizations generated modest savings in the care of Medicare beneficiaries undergoing dialysis when patients received routine care from primary care physicians.

The National Renal Administrators Association sent letters to CMS and the CDC urging the agencies to prioritize issuance of the COVID-19 vaccine to patients with end-stage renal disease and the dialysis clinic staff who provide their care.